关注
Shivee Gilja
Shivee Gilja
在 icahn.mssm.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
EMT and MET: necessary or permissive for metastasis?
MK Jolly, KE Ware, S Gilja, JA Somarelli, H Levine
Molecular Oncology, 2017
4032017
Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2
JA Somarelli, S Shetler, MK Jolly, X Wang, S Bartholf Dewitt, AJ Hish, ...
Molecular and cellular biology 36 (19), 2503-2513, 2016
912016
E-cadherin represses anchorage-independent growth in sarcomas through both signaling and mechanical mechanisms
MK Jolly, KE Ware, S Xu, S Gilja, S Shetler, Y Yang, X Wang, RG Austin, ...
Molecular Cancer Research 17 (6), 1391-1402, 2019
512019
Reconsidering the American joint committee on cancer eighth edition TNM staging manual classifications for T2b and T3 NSCLC
A Kumar, S Kumar, S Gilja, AL Potter, V Raman, A Muniappan, DZ Liou, ...
Journal of Thoracic Oncology 16 (10), 1672-1683, 2021
122021
Induction of mesenchymal-epithelial transitions in sarcoma cells
KE Ware, S Gilja, S Xu, S Shetler, MK Jolly, X Wang, SB Dewitt, AJ Hish, ...
JoVE (Journal of Visualized Experiments), e55520, 2017
102017
Evaluating depth of invasion across oral cavity subsites as part of the AJCC 8th edition T staging criteria for oral cavity squamous cell carcinoma
S Gilja, J Barlow, A Kumar, MH Berger, MN Khan, DN Kirke, SA Roof
Head & Neck 45 (11), 2780-2788, 2023
22023
The Knosp Criteria Revisited: 3-dimensional volumetric analysis as a predictive tool for extent of resection in complex endoscopic pituitary surgery
AC DiRisio, R Feng, WH Shuman, S Platt, G Price, JT Dullea, S Gilja, ...
Neurosurgery 92 (1), 179-185, 2023
22023
Post-operative vision loss: analysis of 587 patients undergoing endoscopic surgery for pituitary macroadenoma
JW Rutland, JT Dullea, EK Oermann, R Feng, DF Villavisanis, S Gilja, ...
British Journal of Neurosurgery 36 (4), 494-500, 2022
22022
Peer‐to‐peer COVID‐19 medical curriculum development during the pandemic.
AT Thomas, S Gilja, N Sikka, O Onuh, R Kellner, L Schussler, M Sun, ...
Medical Education 55 (11), 2021
22021
E-cadherin represses anoikis resistance in sarcomas through both signaling and mechanical mechanisms
MK Jolly, KE Ware, S Xu, S Gilja, S Shetler, Y Yang, X Wang, RG Austin, ...
bioRxiv, 347815, 2018
22018
OA02. 04 Multimodal Management of T4 N2 Non-small-cell Lung Cancer with Additional Ipsilateral Pulmonary Nodules
A Kumar, S Kumar, A Potter, S Gilja, D Liou, CFJ Yang
Journal of Thoracic Oncology 17 (9), S7, 2022
12022
The impact of distance to facility on treatment modality, short-term outcomes, and survival of patients with HPV-positive oropharyngeal squamous cell carcinoma
V Vasan, S Gilja, D Kapustin, J Yun, SA Roof, RL Chai, MN Khan, ...
American Journal of Otolaryngology 45 (4), 104356, 2024
2024
Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors
S Gilja, V Vasan, A Kumar, SA Roof, EM Genden, DN Kirke
Head & Neck 46 (7), 1589-1600, 2024
2024
Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study
J Barlow, S Gilja, RM Ferrandino, MH Berger, MR Posner, RL Bakst, ...
American Journal of Otolaryngology 45 (3), 104243, 2024
2024
The Impact of Hospital Safety‐Net Burden Status on Patients with HPV‐Positive Oropharyngeal Cancer
S Gilja, A Kumar, D Kapustin, V Su, SJ Rubin, R Chai, SA Roof, MN Khan
The Laryngoscope 134 (4), 1733-1740, 2024
2024
Surgery for M1A Non-small-cell Lung Cancer With Additional Pulmonary Nodules in a Contralateral Lobe
A Kumar, S Kumar, S Gilja, CA Mathey-Andrews, AL Potter, CFJ Yang, ...
Journal of Surgical Research 295, 102-111, 2024
2024
Multimodal Therapy for T4 N2 Non–Small Cell Lung Cancer With Additional Ipsilateral Pulmonary Nodules
A Kumar, K Gandhi, S Gilja, AL Potter, C Mathey-Andrews, ...
Annals of Thoracic Surgery Short Reports 1 (4), 566-569, 2023
2023
The impact of undergoing surgical margin evaluation during endoscopic surgery for early‐stage laryngeal squamous cell carcinoma
S Gilja, A Kumar, V Vasan, SA Roof, EM Genden, DN Kirke
Head & Neck 45 (10), 2680-2689, 2023
2023
Encouraging Guideline-Concordant Treatment for T3 NSCLC
A Kumar, S Kumar, S Gilja, A Potter, CFJ Yang
Journal of Thoracic Oncology 16 (12), e98-e99, 2021
2021
MA01. 01 The Role of Surgery for M1a Non-Small-Cell Lung Cancer with Contralateral Lung Involvement
A Kumar, S Kumar, S Gilja, J Copeland, A Potter, C Yang, H Auchincloss
Journal of Thoracic Oncology 16 (10), S885, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20